PA
Profund Advisors Portfolio holdings
AUM
$3.29B
1-Year Est. Return
39.67%
This Fund
S&P 500
1 Year Est. Return
+39.67%
AUM
$3.29B
AUM Growth
+$214M
(+7%)
Holding
1,306
Top Buys
| 1 | +$15.9M | |
| 2 | +$8.37M | |
| 3 | +$6.93M | |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$5.33M |
| 5 |
Seagate
STX
|
+$4.32M |
Top Sells
| 1 | +$28.2M | |
| 2 | +$5.8M | |
| 3 | +$4.35M | |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$3.97M |
| 5 |
Alibaba
BABA
|
+$3.95M |
Sector Composition
| 1 | Technology | 45.99% |
| 2 | Healthcare | 11.64% |
| 3 | Communication Services | 11.05% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Financials | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Madrigal Pharmaceuticals
MDGL
$9.67B
| $2.42M | 0.07% |
4,157
-45
|
|
||
177
PTC Therapeutics
PTCT
$5.32B
| $2.42M | 0.07% |
31,853
+9,591
|
|
||
178
SLB Ltd
SLB
$71.6B
| $2.42M | 0.07% |
63,003
-8,114
|
|
||
179
Coca-Cola
KO
$336B
| $2.42M | 0.07% |
34,548
+1,022
|
|
||
180
Boston Scientific
BSX
$107B
| $2.41M | 0.07% |
25,269
+4,542
|
|
||
181
Travere Therapeutics
TVTX
$2.61B
| $2.39M | 0.07% |
62,604
+42,366
|
|
||
182
Sherwin-Williams
SHW
$86.1B
| $2.39M | 0.07% |
7,381
-570
|
|
||
183
Morgan Stanley
MS
$266B
| $2.38M | 0.07% |
13,418
-3,190
|
|
||
184
Danaher
DHR
$145B
| $2.34M | 0.07% |
10,227
+1,998
|
|
||
185
Vaxcyte
PCVX
$8.65B
| $2.33M | 0.07% |
50,447
+17,525
|
|
||
186
Vale
VALE
$68.6B
| $2.32M | 0.07% |
178,021
+16,962
|
|
||
187
Citigroup
C
$195B
| $2.3M | 0.07% |
19,704
-5,739
|
|
||
188
Moderna
MRNA
$22.8B
| $2.3M | 0.07% |
77,896
+5,159
|
|
||
189
Williams Companies
WMB
$92.6B
| $2.29M | 0.07% |
38,059
-7,078
|
|
||
|
RNAM
190
DELISTED
Avidity Biosciences
RNAM
| $2.28M | 0.07% |
31,642
-6,012
|
|
||
191
Cloudflare
NET
$65.4B
| $2.26M | 0.07% |
11,477
-640
|
|
||
192
Alkermes
ALKS
$4.88B
| $2.26M | 0.07% |
80,624
+36,067
|
|
||
193
Rhythm Pharmaceuticals
RYTM
$6.07B
| $2.25M | 0.07% |
21,046
+8,589
|
|
||
194
Royal Gold
RGLD
$23.8B
| $2.25M | 0.07% |
10,132
+512
|
|
||
195
Pan American Silver
PAAS
$26.1B
| $2.25M | 0.07% |
43,354
-8,663
|
|
||
196
Protagonist Therapeutics
PTGX
$6.05B
| $2.23M | 0.07% |
25,574
+7,417
|
|
||
197
TG Therapeutics
TGTX
$4.63B
| $2.23M | 0.07% |
74,814
+24,569
|
|
||
198
Neurocrine Biosciences
NBIX
$13.2B
| $2.23M | 0.07% |
15,700
+1,631
|
|
||
199
Infosys
INFY
$58B
| $2.21M | 0.07% |
123,841
-70
|
|
||
|
CDTX
200
DELISTED
Cidara Therapeutics
CDTX
| $2.19M | 0.07% |
9,931
+3,156
|
|